Home

Draußen Erfüllen Berri abx464 mechanism of action Blot Jet Optimal

HIV pipeline 2017: full version | HTB | HIV i-Base
HIV pipeline 2017: full version | HTB | HIV i-Base

Specific and selective induction of miR-124 in immune cells by the quinoline ABX464: a transformative therapy for inflammatory diseases - ScienceDirect
Specific and selective induction of miR-124 in immune cells by the quinoline ABX464: a transformative therapy for inflammatory diseases - ScienceDirect

Abivax reports excellent efficacy and safety of ABX464 in Phase IIb
Abivax reports excellent efficacy and safety of ABX464 in Phase IIb

Abivax to evaluate anti-inflammatory effects of ABX464 in large-scale COVID-19 trial – Truffle
Abivax to evaluate anti-inflammatory effects of ABX464 in large-scale COVID-19 trial – Truffle

Targeting the Long Non-Coding RNA LINC00599-205 splicing by novel candidate drug ABX464 to produce the anti-inflammatory microRNA miR-124 | bioRxiv
Targeting the Long Non-Coding RNA LINC00599-205 splicing by novel candidate drug ABX464 to produce the anti-inflammatory microRNA miR-124 | bioRxiv

ABIVAX: 2016 Full-Year Results and Progress Report | Business Wire
ABIVAX: 2016 Full-Year Results and Progress Report | Business Wire

Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis | Retrovirology | Full Text
Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis | Retrovirology | Full Text

Induction and Long-term Follow-up With ABX464 for Moderate-to-severe Ulcerative Colitis: Results of Phase IIa Trial - Gastroenterology
Induction and Long-term Follow-up With ABX464 for Moderate-to-severe Ulcerative Colitis: Results of Phase IIa Trial - Gastroenterology

Frontiers | Microglial Cells: The Main HIV-1 Reservoir in the Brain | Cellular and Infection Microbiology
Frontiers | Microglial Cells: The Main HIV-1 Reservoir in the Brain | Cellular and Infection Microbiology

Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing | Scientific Reports
Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing | Scientific Reports

Abivax's ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for success - Pharma Technology Focus | Issue 98 | September 2020
Abivax's ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for success - Pharma Technology Focus | Issue 98 | September 2020

We develop one of the World's Most Advanced Functional HIV Cure”
We develop one of the World's Most Advanced Functional HIV Cure”

Global Roundup: Abivax Eyes Phase III Following Positive UC Data | BioSpace
Global Roundup: Abivax Eyes Phase III Following Positive UC Data | BioSpace

Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases: Trends in Molecular Medicine
Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases: Trends in Molecular Medicine

Tweets with replies by Abivax (@Abivax_) / Twitter
Tweets with replies by Abivax (@Abivax_) / Twitter

UEG - United European Gastroenterology
UEG - United European Gastroenterology

Abivax: A Biotech With Blockbuster Potential (OTCMKTS:AAVXF) | Seeking Alpha
Abivax: A Biotech With Blockbuster Potential (OTCMKTS:AAVXF) | Seeking Alpha

Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis | Retrovirology | Full Text
Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis | Retrovirology | Full Text

Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing. - Abstract - Europe PMC
Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing. - Abstract - Europe PMC

ABX464's Clinical Benefits for Inflammatory Diseases Revealed in Review
ABX464's Clinical Benefits for Inflammatory Diseases Revealed in Review

Abivax's ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for success - Pharma Technology Focus | Issue 98 | September 2020
Abivax's ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for success - Pharma Technology Focus | Issue 98 | September 2020

Abivax receives Phase IIb trial authorisation from Canada for ABX464
Abivax receives Phase IIb trial authorisation from Canada for ABX464

Abivax First-Half 2018 Financial Results and Operations Update | Abivax
Abivax First-Half 2018 Financial Results and Operations Update | Abivax

ABX 464 | New Drug Approvals
ABX 464 | New Drug Approvals

ABIVAX's ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial | World Pharma Today
ABIVAX's ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial | World Pharma Today

Targeting the Long Non-Coding RNA LINC00599-205 Splicing by Novel Candidate Drug ABX464 To Produce the Anti-Inflammatory MicroRNA MiR-124
Targeting the Long Non-Coding RNA LINC00599-205 Splicing by Novel Candidate Drug ABX464 To Produce the Anti-Inflammatory MicroRNA MiR-124

Specific and selective induction of miR-124 in immune cells by the quinoline ABX464: a transformative therapy for inflammatory diseases - ScienceDirect
Specific and selective induction of miR-124 in immune cells by the quinoline ABX464: a transformative therapy for inflammatory diseases - ScienceDirect

Abivax (@Abivax_) / Twitter
Abivax (@Abivax_) / Twitter

Abivax | LinkedIn
Abivax | LinkedIn

Abivax: Most Ideal Big Pharma M&A Target In 2022 (AAVXF) | Seeking Alpha
Abivax: Most Ideal Big Pharma M&A Target In 2022 (AAVXF) | Seeking Alpha

Mechanism of action of ABX464 [26] | Download Scientific Diagram
Mechanism of action of ABX464 [26] | Download Scientific Diagram